EXEL 2.24 Exelixis Inc $EXEL added to my watch

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

TRIMEDX Recognized as One of the Top Inspiring Workplaces TRIMEDX, a leading name in clinical asset management, has proudly claimed the 30th spot on the 2024 Global Top 100 Inspiring Workplaces list. This esteemed recognition highlights organizations that prioritize people-first practices and create outstanding workplace environments. A Global Overview The Inspiring...

Triumvirate Environmental Announces $1.8 Billion Valuation Triumvirate Environmental, a prominent name in environmental services, has recently received a significant growth investment from Berkshire Partners, a well-respected private equity firm. This monumental partnership has led to Triumvirate being valued at $1.8 billion, a testament to its strong market position and...

The Growth of MSCI Over 15 Years MSCI (NYSE: MSCI) has demonstrated impressive performance over the past decade and a half, significantly outperforming the market. With an annualized return of 20.17%, MSCI has amassed a market capitalization of $43.82 billion. This remarkable performance speaks volumes about the company’s solid market positioning and timely strategic...

Deckers Outdoor Impresses with Strong Financial Results Shares of Deckers Outdoor Corporation (NYSE: DECK) have recently experienced a notable increase in value. This uplift can be attributed to the company's impressive second-quarter earnings, which surpassed analysts' expectations. The casual footwear and apparel retailer reported revenue of $1.31 billion, significantly...

Vitrolife AB Strengthens Financial Backbone Vitrolife AB (publ) has taken a significant step towards enhancing its financial foundation by renewing and signing a loan agreement worth EUR 300 million. This strategic financial maneuver includes both a term loan and a revolving credit facility, aimed at refinancing existing debt while also providing resources for general...